BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 19081021)

  • 1. Multimodal treatment of sporadic and inherited neuroendocrine tumors of the thymus.
    Habbe N; Waldmann J; Bartsch DK; Fendrich V; Rothmund M; Langer P
    Surgery; 2008 Nov; 144(5):780-5. PubMed ID: 19081021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastrinomas associated with MEN-1 syndrome: new insights for the diagnosis and management in a series of 11 patients.
    Nikou GC; Toubanakis C; Nikolaou P; Giannatou E; Marinou K; Safioleas M; Karamanolis D
    Hepatogastroenterology; 2005; 52(66):1668-76. PubMed ID: 16334754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Operative management and long-term survival in patients with neuroendocrine tumors of the pancreas--experience with 144 patients].
    Fendrich V; Habbe N; Celik I; Langer P; Zielke A; Bartsch DK; Rothmund M
    Dtsch Med Wochenschr; 2007 Feb; 132(5):195-200. PubMed ID: 17252361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thymic neuroendocrine tumour in multiple endocrine neoplasia type 1: female patients are not rare exceptions.
    Sakurai A; Imai T; Kikumori T; Horiuchi K; Okamoto T; Uchino S; Kosugi S; Suzuki S; Suyama K; Yamazaki M; Sato A;
    Clin Endocrinol (Oxf); 2013 Feb; 78(2):248-54. PubMed ID: 22690831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatostatin-producing neuroendocrine tumors of the duodenum and pancreas: incidence, types, biological behavior, association with inherited syndromes, and functional activity.
    Garbrecht N; Anlauf M; Schmitt A; Henopp T; Sipos B; Raffel A; Eisenberger CF; Knoefel WT; Pavel M; Fottner C; Musholt TJ; Rinke A; Arnold R; Berndt U; Plöckinger U; Wiedenmann B; Moch H; Heitz PU; Komminoth P; Perren A; Klöppel G
    Endocr Relat Cancer; 2008 Mar; 15(1):229-41. PubMed ID: 18310290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thymic carcinoid in multiple endocrine neoplasia 1: genotype-phenotype correlation and prevention.
    Lim LC; Tan MH; Eng C; Teh BT; Rajasoorya RC
    J Intern Med; 2006 Apr; 259(4):428-32. PubMed ID: 16594911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple endocrine neoplasia type 1 in Japan: establishment and analysis of a multicentre database.
    Sakurai A; Suzuki S; Kosugi S; Okamoto T; Uchino S; Miya A; Imai T; Kaji H; Komoto I; Miura D; Yamada M; Uruno T; Horiuchi K; Miyauchi A; Imamura M; ; Fukushima T; Hanazaki K; Hirakawa S; Igarashi T; Iwatani T; Kammori M; Katabami T; Katai M; Kikumori T; Kiribayashi K; Koizumi S; Midorikawa S; Miyabe R; Munekage T; Ozawa A; Shimizu K; Sugitani I; Takeyama H; Yamazaki M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):533-9. PubMed ID: 21950691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing effective screening strategies in multiple endocrine neoplasia type 1 (MEN 1) on the basis of clinical and sequencing data of German patients with MEN 1.
    Schaaf L; Pickel J; Zinner K; Hering U; Höfler M; Goretzki PE; Spelsberg F; Raue F; von zur Mühlen A; Gerl H; Hensen J; Bartsch DK; Rothmund M; Schneyer U; Dralle H; Engelbach M; Karges W; Stalla GK; Höppner W
    Exp Clin Endocrinol Diabetes; 2007 Sep; 115(8):509-17. PubMed ID: 17853334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NANETS consensus guideline for the diagnosis and management of neuroendocrine tumors: well-differentiated neuroendocrine tumors of the thorax (includes lung and thymus).
    Phan AT; Oberg K; Choi J; Harrison LH; Hassan MM; Strosberg JR; Krenning EP; Kocha W; Woltering EA; Maples WJ;
    Pancreas; 2010 Aug; 39(6):784-98. PubMed ID: 20664476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret Hospital.
    Rothenstein J; Cleary SP; Pond GR; Dale D; Gallinger S; Moore MJ; Brierley J; Siu LL
    Am J Clin Oncol; 2008 Feb; 31(1):64-70. PubMed ID: 18376230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism.
    Yip L; Ogilvie JB; Challinor SM; Salata RA; Thull DL; Yim JH; Carty SE
    Surgery; 2008 Dec; 144(6):1002-6; discussion 1006-7. PubMed ID: 19041010
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroendocrine Tumors of the Thymus: Analysis of Factors Affecting Survival in 254 Patients.
    Sullivan JL; Weksler B
    Ann Thorac Surg; 2017 Mar; 103(3):935-939. PubMed ID: 27720367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Association of Blood Type O With Neuroendocrine Tumors in Multiple Endocrine Neoplasia Type 1.
    Nell S; van Leeuwaarde RS; Pieterman CR; de Laat JM; Hermus AR; Dekkers OM; de Herder WW; van der Horst-Schrivers AN; Drent ML; Bisschop PH; Havekes B; Borel Rinkes IH; Vriens MR; Valk GD
    J Clin Endocrinol Metab; 2015 Oct; 100(10):3850-5. PubMed ID: 26247473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New therapies for patients with multiple endocrine neoplasia type 1.
    Geslot A; Vialon M; Caron P; Grunenwald S; Vezzosi D
    Ann Endocrinol (Paris); 2021 Apr; 82(2):112-120. PubMed ID: 33839123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for multiple endocrine neoplasia type 1 and hormonal production in apparently sporadic neuroendocrine tumors.
    Baudin E; Bidart JM; Rougier P; Lazar V; Ruffié P; Ropers J; Ducreux M; Troalen F; Sabourin JC; Comoy E; Lasser P; DeBaere T; Schlumberger M
    J Clin Endocrinol Metab; 1999 Jan; 84(1):69-75. PubMed ID: 9920064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymic neuroendocrine carcinoma (carcinoid) in multiple endocrine neoplasia type 1 syndrome: the Italian series.
    Ferolla P; Falchetti A; Filosso P; Tomassetti P; Tamburrano G; Avenia N; Daddi G; Puma F; Ribacchi R; Santeusanio F; Angeletti G; Brandi ML
    J Clin Endocrinol Metab; 2005 May; 90(5):2603-9. PubMed ID: 15713725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and prognostic implications of the genetic diagnosis of hereditary NET syndromes in asymptomatic patients.
    Ramundo V; Milone F; Severino R; Savastano S; Di Somma C; Vuolo L; De Luca L; Lombardi G; Colao A; Faggiano A
    Horm Metab Res; 2011 Oct; 43(11):794-800. PubMed ID: 22009375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic neuroendocrine tumors: presentation, management, and outcomes.
    Nissen NN; Kim AS; Yu R; Wolin EM; Friedman ML; Lo SK; Wachsman AM; Colquhoun SD
    Am Surg; 2009 Oct; 75(10):1025-9. PubMed ID: 19886158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prevalence of the neuroendocrine phenotype in thymus neoplasms].
    Ferolla P; Urbani M; Ascani S; Puma F; Ribacchi R; Battista Bolis G; Santeusanio F; Daddi G; Angeletti G; Avenia N
    Chir Ital; 2002; 54(3):351-4. PubMed ID: 12192931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.